Is Dapsone Still Relevant in Immune Thrombocytopenia in Resource Limited Settings?

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2019 Dec 22

PMID 31862814

Authors

Preeti Dalal

Manisha Gulia

Monica Gupta

Anita Tahlan

Affiliations

Soon will be listed here.

Abstract

Immune thrombocytopenia is an autoimmune disorder characterised by autoantibody production against platelets, increased platelet destruction and impaired thrombopoiesis. Steroids are the first-line agents whenever treatment is indicated; however, some patients may not respond and the responders may as well relapse while the dose is being tapered. Side effects of steroids prohibits their long-term use and patients often have to be switched to other agents. Standard drug management with intravenous immunoglobulins and thrombopoietin receptor analogues is difficult to administer in patients from low socioeconomic regions of the world making the management even more challenging. Hence, after reviewing the literature and considering the cost in comparison to all the second-line agents available, we tried dapsone in a steroid-dependent patient of immune thrombocytopenic purpura who had developed major steroid-related side effects. Patient showed good response to dapsone and has been in remission for around one and a half years.

References

Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R . Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. Am J Hematol. 2011; 87(3):321-3. DOI: 10.1002/ajh.22266. View

Hou M, Peng J, Shi Y, Zhang C, Qin P, Zhao C . Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura. Eur J Haematol. 2003; 70(6):353-7. DOI: 10.1034/j.1600-0609.2003.00076.x. View

Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther M . The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011; 117(16):4190-207. DOI: 10.1182/blood-2010-08-302984. View

Komoglu S, Silte D, Sertbas M, Sertbas Y, Ozdemir A . Methorexate therapy in a patient with rheumatoid arthritis complicated by idiopathic thrombocytopenic purpura. Eur J Rheumatol. 2016; 2(1):39-40. PMC: 5047244. DOI: 10.5152/eurjrheumatol.2014.14065. View

Godeau B, Durand J, Roudot-Thoraval F, Tenneze A, Oksenhendler E, Kaplanski G . Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br J Haematol. 1997; 97(2):336-9. DOI: 10.1046/j.1365-2141.1997.412687.x. View

Vancine-Califani S, De Paula E, Castro Ozelo M, Orsi F, Fabri D, Annichino-Bizzacchi J . Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Platelets. 2008; 19(7):489-95. DOI: 10.1080/09537100802315110. View

Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S . Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia. Am J Hematol. 2012; 87(9):886-9. DOI: 10.1002/ajh.23272. View

Quiquandon I, Fenaux P, Caulier M, Pagniez D, Huart J, Bauters F . Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases. Br J Haematol. 1990; 74(2):223-8. DOI: 10.1111/j.1365-2141.1990.tb02569.x. View

Mithoowani S, Gregory-Miller K, Goy J, Miller M, Wang G, Noroozi N . High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2016; 3(10):e489-e496. DOI: 10.1016/S2352-3026(16)30109-0. View

10.

Patel A, Patil A . Dapsone for immune thrombocytopenic purpura in children and adults. Platelets. 2014; 26(2):164-7. DOI: 10.3109/09537104.2014.886677. View

11.

Hill Q . How does dapsone work in immune thrombocytopenia? Implications for dosing. Blood. 2015; 125(23):3666-8. DOI: 10.1182/blood-2015-03-632000. View

12.

Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A . Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Eur J Haematol. 2005; 75(4):328-31. DOI: 10.1111/j.1600-0609.2005.00545.x. View

13.

Godeau B, Oksenhendler E, Bierling P . Dapsone for autoimmune thrombocytopenic purpura. Am J Hematol. 1993; 44(1):70-2. DOI: 10.1002/ajh.2830440117. View

14.

Facon T, Caulier M, Wattel E, Jouet J, Bauters F, Fenaux P . A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients. Br J Haematol. 1994; 86(3):678-80. DOI: 10.1111/j.1365-2141.1994.tb04810.x. View

15.

Hernandez F, Linares M, Colomina P, Pastor E, Cervero A, Perez A . Dapsone for refractory chronic idiopathic thrombocytopenic purpura. Br J Haematol. 1995; 90(2):473-5. DOI: 10.1111/j.1365-2141.1995.tb05179.x. View

16.

Linares M, Cervero A, Pastor E, Colomina P . Dapsone for idiopathic thrombocytopenic purpura. Am J Hematol. 1994; 46(4):371-2. DOI: 10.1002/ajh.2830460423. View

17.

Esteve C, Samson M, Guilhem A, Nicolas B, Leguy-Seguin V, Berthier S . Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients. PLoS One. 2017; 12(10):e0187296. PMC: 5662230. DOI: 10.1371/journal.pone.0187296. View